Double Bond Pharmaceutical (DBP) has signed an agreement with Zoono for the distribution of selected products in the Scandinavian market. The sale of these products will be handled by it’s subsidiary Drugsson AB.
Zoono provides cost effective, polymer based, broad-spectrum antimicrobial protection. The products are effective against bacteria, viruses, fungi (mould), yeasts, pathogens incl. MRSA, E.Coli, H1N1, Listeria, TB, black mould, Norovirus etc.
Drugsson will market the products to both consumers (self-care) and healthcare, which shows that the products have a broad market.